---
title: "Dr. Timothy Lubenow moved from academia to MAPS Centers for Pain Control in Chicago, bringing advanced relief directly to patients."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273147519.md"
description: "Dr. Timothy R. Lubenow has transitioned from his role as Chair of Pain Medicine at Rush University to join MAPS Centers for Pain Control in Chicago as of January 20, 2026. With a career beginning in the 1980s as an anesthesiology resident, Dr. Lubenow's move marks a significant shift in the healthcare landscape, bringing extensive experience and expertise to the new position."
datetime: "2026-01-20T23:46:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273147519.md)
  - [en](https://longbridge.com/en/news/273147519.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273147519.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273147519.md) | [繁體中文](https://longbridge.com/zh-HK/news/273147519.md)


# Dr. Timothy Lubenow moved from academia to MAPS Centers for Pain Control in Chicago, bringing advanced relief directly to patients.

Dr. Timothy R. Lubenow, previously the Chair of Pain Medicine at Rush University, has recently joined MAPS Centers for Pain Control based in Chicago on January 20, 2026. Dr. Lubenow, who originally began his career at Rush as an anesthesiology resident in the 1980s, witnessed the evolution of pain medicine during his tenure there. This move signifies a significant change in the healthcare landscape, with Dr. Lubenow bringing a wealth of experience and knowledge to MAPS Centers for Pain Control.

## Related News & Research

- [Omeros Turns Corner With Novo Deal, YARTEMLEA Launch](https://longbridge.com/en/news/281666535.md)
- [01:40 ETVARON Marks Earth Hour 2026 with a Call for Sustainable Respiratory Care and Climate Action](https://longbridge.com/en/news/281607445.md)
- [SpaceX IPO: Will It Be a Buy or a Bust?](https://longbridge.com/en/news/281674034.md)
- [The High-Bandwidth Memory (HBM) Bottleneck Can Still Cause Micron's Stock to Soar](https://longbridge.com/en/news/281662827.md)
- [Shenzhen Xunce Technology Co., Ltd. Class H (3317): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/281611713.md)